Mangoceuticals (MGRX) risk factors

Item 1A of every Mangoceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open MGRX in Gloom →

Mangoceuticals' chart, financials and news, free in your browser.Open MGRX in Gloom →

FY2025 10-K risk factors
90 risks8 new8 reworded
Solana treasury risks now dominate, including volatility, liquidity, lending losses, cybersecurity, and possible securities-law treatment.
Filed Apr 01, 2026
FY2024 10-K risk factors
82 risks
Mangoceuticals relies entirely on related-party pharmacy Epiq Scripts, controlled by its CEO, to compound its unapproved pharmaceutical products. The company faces a going concern risk, intense competition, and extensive regulation of telehealth and compounding.
Filed Mar 20, 2025